v3.24.3
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
OPERATING ACTIVITIES:    
Net income (loss) $ 1,829 $ 2,135
Adjustments to reconcile to net cash provided (used) by operating activities:    
Depreciation and amortization 1,654 1,542
Provision (benefit) for deferred income taxes 467 586
Equity (earnings) losses (431) (434)
Distributions from equity-method investees 580 607
Net unrealized (gain) loss from commodity derivative instruments 210 (433)
Gain on sale of business (Note 3) 0 (130)
Gain on disposition of equity-method investments (Note 3) (149) 0
Gain on consolidation of equity-method investments (Note 3) (127) 0
Inventory write-downs 8 28
Amortization of stock-based awards 69 59
Cash provided (used) by changes in current assets and liabilities:    
Accounts receivable 367 1,295
Inventories (6) 29
Other current assets and deferred charges (16) (5)
Accounts payable (317) (1,072)
Accrued and other current liabilities (108) (114)
Changes in current and noncurrent commodity derivative assets and liabilities (74) 172
Other, including changes in noncurrent assets and liabilities (200) (140)
Net cash provided (used) by operating activities 3,756 4,125
FINANCING ACTIVITIES:    
Proceeds from (payments of) commercial paper – net (723) (352)
Proceeds from long-term debt 3,594 2,754
Payments of long-term debt (2,286) (21)
Payments for debt issuance costs (31) (21)
Proceeds from issuance of common stock 8 8
Purchases of treasury stock 0 (130)
Common dividends paid (1,737) (1,635)
Dividends and distributions paid to noncontrolling interests (178) (174)
Contributions from noncontrolling interests 36 18
Other – net (34) (19)
Net cash provided (used) by financing activities (1,351) 428
INVESTING ACTIVITIES:    
Capital expenditures (1) (1,805) (1,845)
Dispositions – net (73) (33)
Proceeds from sale of business (Note 3) 0 348
Purchases of businesses, net of cash acquired (Note 3) (1,995) (1,024)
Proceeds from dispositions of equity-method investments (Note 3) 161 0
Purchases of and contributions to equity-method investments (101) (80)
Other – net 20 3
Net cash provided (used) by investing activities (3,793) (2,631)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (1,388) 1,922
Cash and cash equivalents at beginning of year 2,150 152
Cash and cash equivalents at end of period 762 2,074
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]    
(1)  Increases to property, plant, and equipment (1,840) (1,960)
Changes in related accounts payable and accrued liabilities 35 115
Capital expenditures $ (1,805) $ (1,845)